Identification of a key amino acid of the β2-adrenergic receptor for high affinity binding of salmeterol

Molecular Pharmacology

Volumn 54, Issue 4, 1998, Pages 616-622

  Isogaya, Masafumi ^a,c   Yamagiwa, Yoko ^b   Fujita, Shigeo ^b   Sugimoto, Yoshiyuki ^a   Nagao, Taku ^a   Kurose, Hitoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETAXOLOL; OXYGEN; SALMETEROL; SALMETEROL DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADRENERGIC BETA-AGONISTS; ALANINE; ALBUTEROL; AMINO ACID SEQUENCE; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADRENERGIC, BETA-2; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031752778     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 2-adrenoceptor agonists. Trends Pharmacol Sci 17:324-330.
2. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
3. Dixon RA, Hill WS, Candelore MR, Rands E, Diehl RE, Marshall MS, Sigal IS, and Strader CD (1989) Genetic analysis of the molecular basis for β-adrenergic receptor subtype specificity. Proteins 6:267-274.
4. Dixon RAF, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, and Strader CD (1987) Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core. Nature (Lond) 326:73-77.
5. 2-adrenergic receptor. Biochemistry 27:1813-1817.
6. 2-adrenergic receptors. Proc Natl Acad Sci USA 85:9494-9498.
7. 2-adrenergic receptor. J Biol Chem 271:24029-24035.
8. 2-adrenergic receptor ligand binding pocket. Mol Pharmacol 49:1021-1032.
9. Johnson M (1995) Salmeterol. Med Res Rev 15:225-257.
10. 2-selective agonist, TA-2005. Mol Pharmacol 53:128-134.
11. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
12. 2-adrenergic receptors involves multiple subsites. EMBO (Eur Mol Biol Organ) J 9:1471-1476.
13. Mizushima S and Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322.
14. Perlman JH, Colson A-O, Wang W, Bence K, Osman R, and Gershengorn MC (1997) Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. J Biol Chem 272:11937-11942.
15. Rosenkilde MM, Cahir M, Gether U, Hjorth SA, and Schwartz TW (1994) Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269:28160-28164.
16. Sanger F, Nicklen S, and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
17. Savarese TM and Fraser CM (1992) In vitro mutagenesis and search for structure-function relationships among G protein-coupled receptors. Biochem J 283:1-19.
18. Schwartz TW and Rosenkilde MM (1996) Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sci 17:213-216.
19. 2A receptor. J Biol Chem 270:16683-16688.
20. Strader CD, Candelore MR, Hill WS, Sigal IS, and Dixon RAF (1989) Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem 264:13572-13578.
21. Strader CD, Fong TM, Graziano MP, and Tota MR (1995) The family of G-protein-coupled receptors. FASEB J 9:745-754.
22. Strader CD, Fong TM, Tota MR, Underwood D, and Dixon RAF (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
23. Strader CD, Sigal IS, Candelore MR, Hill WS, and Dixon RAF (1988) Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J Biol Chem 263:10267-10271.
24. Wong SK-F, Slaughter C, Ruoho AE, and Ross EM (1988) The catecholamine binding site of the β-adrenergic receptor is formed by juxtaposed membrane-spanning domains. J Biol Chem 263:7925-7928.
25. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, and Sealfon SC (1994) A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 45: 165-170.